The Association for Professionals in Infection Control and Epidemiology (APIC) has named Robert T. Van Hook as its interim CEO effective Oct. 18.
Van Hook will manage APICs day-to-day affairs while the association conducts a search for a successor to Kathy Warye who served as APICs CEO since 2004. The search for Waryes successor is expected to take six months. Van Hook will not be a candidate for the successor CEO position.
"I am excited about the opportunity to return to my public health roots in my role as interim CEO at APIC," says Van Hook. "I hope that during the transition we can build upon Kathy Waryes excellent work and set the stage at APIC for a new CEO."
Van Hook has been an association executive for more than 25 years, leading nonprofit and governmental organizations at the local, state and national levels. He is currently president of Transition Management Consulting, Inc., a Washington, D.C.-based company that specializes in providing interim executive management and transition consulting to associations and nonprofits.
Since co-founding Transition Management Consulting in 2000, Van Hook has served as interim executive for numerous organizations, including the Center for American Nurses, Society for Interventional Radiology, American Institute of Architects, American Geophysical Union and the Association of State and Provincial Psychology Boards.
"We are delighted that Bob has agreed to guide us through this transition," said APIC 2010 president Cathryn Murphy, RN, PhD, CIC. "With his extensive experience in association management and interim executive engagement, we believe he is the right person to work with APIC through our executive leadership succession."
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.